FDA Import Refusal 8V8-0000195-1/11/2 — Zhejiang Peptites Biotech Co.,Ltd.
The FDA refused shipment 8V8-0000195-1/11/2 from Zhejiang Peptites Biotech Co.,Ltd. (China) on September 27, 2023. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 2280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- September 27, 2023
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 61PDT72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 2280